Novartis AG

NVS.BA·Buenos Aires·Healthcare
Compare
62,275.00−1,575.00 (−2.47%)today
At close: Oct 23, 4:59 PM ART · May be delayed up to 20 min · ARS

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close63,850.00
Open63,800.00
Day range61,600.0064,100.00
52-week range43,680.0067,200.00
Off day high−2.85%
Off 52-week high−7.33%
Volume3.29K
Avg. volume (3M)534
Market cap59.18T
EPS (TTM)18,514.33
Forward P/E—
P/E ratio (TTM)3.36
Dividend yield2.63% (1,657.95)
Beta (5Y)0.47
Shares outstanding950.36M
Short interest—
Earnings dateJul 17, 2025
Analyst target—
Profit margin22.50%

Against its peers

Compare in full ›
NVS.BA AMGN BIIB AZN REC.MI MRK
Market cap 59.18T 237.48B 37.04B 265.96B 11.19B 358.41B
P/E (TTM) 3.4 27.3 44.5 25.8 22.6 117.2
Forward P/E — 17.9 15.2 15.1 14.2 15.7
Price/book 1.9 20.3 2.0 5.3 5.2 8.6
Dividend yield 2.63% 2.29% — 1.87% 2.68% 2.34%
1-year change +25.13% +50.87% +66.65% +2.00% +2.32% +65.08%
Today −2.47% −1.79% −1.24% −0.63% +1.61% −1.34%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Novartis's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Amgen Inc.AMGN · Drug Manufacturers - General 237.48B 439.26 −1.79%
Biogen Inc.BIIB · Drug Manufacturers - General 37.04B 250.69 −1.24%
AstraZeneca PLCAZN · Drug Manufacturers - General 265.96B 171.49 −0.63%
Recordati Industria Chimica e Farmaceutica S.p.A.REC.MI · Drug Manufacturers - General 11.19B 53.80 +1.61%
Merck & Co., Inc.MRK · Drug Manufacturers - GeneralOdds 358.41B 145.27 −1.34%
Daiichi Sankyo Company, LimitedD4S.F · Drug Manufacturers - General 28.63B 15.73 −0.51%
SanofiSNY · Drug Manufacturers - General 99.68B 41.60 −0.86%
NGL Fine-Chem LimitedNGLFINE.BO · Drug Manufacturers - General 16.34B 2,644.20 −0.43%

The stocks whose daily moves over the past year went most closely with Novartis's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
AstraZeneca PLCAZN.BA · Correlation 0.66 109.73T 70,750.00 −0.04%
Amgen Inc.AMGN.BA · Correlation 0.64 2.61T 24,160.00 −1.23%
Amgen Inc.AMGN · Correlation 0.55 237.48B 439.26 −1.79%
AstraZeneca PLCAZN · Correlation 0.50 265.96B 171.49 −0.63%
Merck & Co., Inc.MRK.BA · Correlation 0.49 11.81T 47,860.00 −1.48%
SanofiSNY · Correlation 0.38 99.68B 41.60 −0.86%
Merck & Co., Inc.MRK · Correlation 0.38Odds 358.41B 145.27 −1.34%

What visitors to Novartis's page also look at.

Company Mkt cap Price Today
MERCK & CO INC CEDEAR (5 REP 1MRK.BA 11.81T 47,860.00 −1.48%
AMGEN INC CEDEAR EACH 30 REP 1AMGN.BA 2.61T 24,160.00 −1.23%
TEXAS INSTRUMENTS INC CEDEAR EATXN.BA 17.15T 93,875.00 +2.51%
SAP SE CEDEAR EACH 6 REP 1SAP.BA 25.22T 65,550.00 −0.15%
ASTRAZENECA PLC CEDEAR EACH REPAZN.BA 109.73T 70,750.00 −0.04%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NVS.BA news ›
Seeking Alpha·

Novartis: The Sell-Off Creates An Attractive Entry Point

Novartis Q3 earnings Oct 27: revenue growth, oncology strength & Cosentyx EMA news. Click here to read my most recent analysis of NVS stock. - On October 27, Novartis will report its results for the third quarter. - As a reminder, its Q2…

pharmaphorum·

Novartis abandons Fabhalta trial in lupus nephritis

A failed phase 2 study has undermined Novartis' hopes of extending the approved indications for its oral complement inhibitor Fabhalta to include lupus nephritis. According to an update on the clinicaltrials.gov registry website, Novartis…

From articles in the 4Search news index.

In the news

128mentions in 30 days
117with it in the headline
Mixedsentiment

Mentioned with

Eli Lilly87Astrazeneca69Novo Nordisk69Novartis AG59Pfizer47Google35Sanofi34Abogen Biosciences33

People in the coverage

Vas Narasimhan58Abogen46Alteogen43Moderna43Ruchika Khanna40Subhranshu Sahu40

Themes

Biotech52Pharmaceuticals43Health40Conservative Talk38Brian Kilmeade37Pharma37Clay Travis35Biopharma32

Most coverage from

  1. marketscreener.com27
  2. tradingview.com8
  3. openpr.com5
  4. novartis.com4
  5. theglobeandmail.com4

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.